Cubist Systematic Strategies, LLC Pfizer Inc Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 13,700 shares of PFE stock, worth $321,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,700

Previous 32,976 58.45%

Holding current value

$321,402

Previous $874,000 60.3%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $817,804 - $995,545	32,976 New	32,976 $874,000
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $3.59 Million - $4.2 Million	141,926 Added 25.46%	699,465 $19.6 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $12.8 Million - $14.7 Million	495,488 Added 798.52%	557,539 $15.5 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.35 Million - $1.76 Million	51,822 Added 506.62%	62,051 $1.79 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $1.24 Million - $1.45 Million	-38,576 Reduced 79.04%	10,229 $339,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $2.24 Million - $2.59 Million	-61,982 Reduced 55.95%	48,805 $1.79 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $3.65 Million - $4.76 Million	92,769 Added 514.87%	110,787 $4.52 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $7.86 Million - $10.3 Million	-188,263 Reduced 91.27%	18,018 $923,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $5.81 Million - $7.09 Million	-132,787 Reduced 39.16%	206,281 $9.03 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $3.77 Million - $4.46 Million	-80,924 Reduced 19.27%	339,068 $17.8 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $3.4 Million - $4.21 Million	74,252 Added 21.48%	419,992 $21.7 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $6.14 Million - $9.11 Million	-148,705 Reduced 30.08%	345,740 $20.4 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $10.1 Million - $13 Million	257,062 Added 108.29%	494,445 $21.3 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $3.65 Million - $4.14 Million	101,698 Added 74.95%	237,383 $9.3 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $476,395 - $537,278	-14,225 Reduced 9.49%	135,685 $4.92 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $4.65 Million - $5.92 Million	-138,993 Reduced 48.11%	149,910 $5.52 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $2.03 Million - $2.38 Million	-63,822 Reduced 18.09%	288,903 $10.6 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $11.5 Million - $14 Million	-382,702 Reduced 52.04%	352,725 $11.5 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $12.1 Million - $17.3 Million	448,966 Added 156.73%	735,427 $24 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $4.7 Million - $5.33 Million	142,790 Added 99.39%	286,461 $11.2 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $2.8 Million - $3.62 Million	-86,040 Reduced 37.46%	143,671 $5.16 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $7.73 Million - $8.67 Million	208,906 Added 1004.11%	229,711 $9.95 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $1.37 Million - $1.5 Million	-36,527 Reduced 63.71%	20,805 $884,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $1.59 Million - $1.81 Million	41,278 Added 257.12%	57,332 $2.5 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $2.81 Million - $3.41 Million	-81,584 Reduced 83.56%	16,054 $707,000
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $193,790 - $206,600	5,876 Added 6.4%	97,638 $3.54 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $1.58 Million - $1.83 Million	-49,398 Reduced 34.99%	91,762 $3.26 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $4.69 Million - $4.98 Million	141,160	141,160 $5.11 Million

Others Institutions Holding PFE

# of Institutions

3,368

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $132B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Pfizer Inc Transaction History